| Item Type | Name |
|
Academic Article
|
Comparison of trivalent cold-adapted recombinant (CR) influenza virus vaccine with monovalent CR vaccines in healthy unselected adults.
|
|
Academic Article
|
Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly.
|
|
Academic Article
|
Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice.
|
|
Academic Article
|
Respiratory viral infections in adults with and without chronic obstructive pulmonary disease.
|
|
Academic Article
|
Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid.
|
|
Academic Article
|
Infections in Hispanic immigrants.
|
|
Academic Article
|
Influenza vaccine in patients with asthma.
|
|
Academic Article
|
B-cell activation and differentiation by HIV-1 antigens among volunteers vaccinated with VaxSyn HIV-1.
|
|
Academic Article
|
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network.
|
|
Academic Article
|
Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy.
|
|
Academic Article
|
Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans.
|
|
Academic Article
|
Adjuvants for pandemic influenza vaccines.
|
|
Academic Article
|
Inactivated influenza vaccination for people with spinal cord injury.
|
|
Academic Article
|
Norovirus vaccine against experimental human Norwalk Virus illness.
|
|
Academic Article
|
Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.
|
|
Academic Article
|
Direct comparison of an inactivated subvirion influenza A virus subtype H5N1 vaccine administered by the intradermal and intramuscular routes.
|
|
Academic Article
|
Evaluations for in vitro correlates of immunogenicity of inactivated influenza a H5, H7 and H9 vaccines in humans.
|
|
Academic Article
|
Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons.
|
|
Academic Article
|
A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults.
|
|
Academic Article
|
Preparing for a possible pandemic: influenza A/H5N1 vaccine development.
|
|
Academic Article
|
Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults.
|
|
Academic Article
|
Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans.
|
|
Academic Article
|
A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route.
|
|
Academic Article
|
A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects.
|
|
Academic Article
|
Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine.
|
|
Academic Article
|
Intanza(?): a new intradermal vaccine for seasonal influenza.
|
|
Academic Article
|
High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults.
|
|
Academic Article
|
Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants.
|
|
Academic Article
|
Effect of live attenuated, cold recombinant (CR) influenza virus vaccines on pulmonary function in healthy and asthmatic adults.
|
|
Academic Article
|
Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemic.
|
|
Academic Article
|
Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus.
|
|
Academic Article
|
Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines.
|
|
Academic Article
|
Prenatal passive transfer of maternal immunity in Asian elephants (Elephas maximus).
|
|
Concept
|
Japanese Encephalitis Vaccines
|
|
Concept
|
Vaccines, Inactivated
|
|
Concept
|
Vaccines
|
|
Concept
|
Vaccines, Attenuated
|
|
Concept
|
Vaccines, DNA
|
|
Concept
|
Ebola Vaccines
|
|
Concept
|
Protozoan Vaccines
|
|
Concept
|
Malaria Vaccines
|
|
Concept
|
Viral Vaccines
|
|
Concept
|
Vaccines, Synthetic
|
|
Concept
|
Rabies Vaccines
|
|
Concept
|
Vaccines, Combined
|
|
Concept
|
Influenza Vaccines
|
|
Concept
|
Bacterial Vaccines
|
|
Concept
|
Rotavirus Vaccines
|
|
Concept
|
Anthrax Vaccines
|
|
Concept
|
AIDS Vaccines
|
|
Concept
|
Dengue Vaccines
|
|
Academic Article
|
Epidemiology of human noroviruses and updates on vaccine development.
|
|
Academic Article
|
A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults.
|
|
Academic Article
|
Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccine.
|
|
Academic Article
|
Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.
|
|
Academic Article
|
Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults.
|
|
Academic Article
|
Serological Correlates of Protection against a GII.4 Norovirus.
|
|
Academic Article
|
Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial.
|
|
Academic Article
|
Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine.
|
|
Academic Article
|
Influenza Vaccination of Patients Receiving Statins: Where Do We Go From Here?
|
|
Academic Article
|
Serological Responses to a Norovirus Nonstructural Fusion Protein after Vaccination and Infection.
|
|
Academic Article
|
Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go?
|
|
Academic Article
|
Antiviral targets of human noroviruses.
|
|
Academic Article
|
Rapid Responses to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: A Randomized Controlled Trial.
|
|
Academic Article
|
B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine.
|
|
Academic Article
|
Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial.
|
|
Academic Article
|
Prospects and Challenges in the Development of a Norovirus Vaccine.
|
|
Academic Article
|
An Exploratory Study of the Salivary Immunoglobulin A Responses to 1 Dose of a Norovirus Virus-Like Particle Candidate Vaccine in Healthy Adults.
|
|
Academic Article
|
Human noroviruses: recent advances in a 50-year history.
|
|
Academic Article
|
Influenza Vaccines After 7 Decades: Still on the Learning Curve.
|
|
Academic Article
|
Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination.
|
|
Academic Article
|
Persistence of Antibodies to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: 1-Year Follow-up With Memory Probe Vaccination.
|
|
Concept
|
Vaccines, Virus-Like Particle
|
|
Academic Article
|
Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A/H5N1 vaccines: A meta-analysis.
|
|
Academic Article
|
Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents.
|
|
Academic Article
|
A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area.
|
|
Academic Article
|
Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices.
|
|
Academic Article
|
Comparison of Microneutralization and Histo-Blood Group Antigen-Blocking Assays for Functional Norovirus Antibody Detection.
|
|
Academic Article
|
Searching for Improved Flu Vaccines-The Time Is Now.
|
|
Academic Article
|
Corrigendum to : Influenza Vaccines After 7 Decades: Still on the Learning Curve.
|
|
Academic Article
|
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019.
|
|
Academic Article
|
An evaluation of cytokine and cellular immune responses to heterologous prime-boost vaccination with influenza A/H7N7-A/H7N9 inactivated vaccine.
|
|
Academic Article
|
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season.
|
|
Academic Article
|
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
|
|
Academic Article
|
Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020.
|
|
Academic Article
|
Topical Imiquimod Does Not Provide an Adjuvant Effect When Administered With Inactivated Influenza A/H5N1 Vaccine in Healthy Young Adults.
|
|
Academic Article
|
Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses.
|
|
Academic Article
|
Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021.
|
|
Academic Article
|
Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations - United States, 2021.
|
|
Academic Article
|
Homologous and Heterologous Covid-19 Booster Vaccinations.
|
|
Academic Article
|
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant.
|
|
Academic Article
|
A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults.
|
|
Academic Article
|
Safety and immunogenicity of Multimeric-001 (M-001) followed by seasonal quadrivalent inactivated influenza vaccine in young adults - A randomized clinical trial.
|
|
Academic Article
|
A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area.
|
|
Academic Article
|
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
|
|
Academic Article
|
Histo-Blood Group Antigen Null Phenotypes Associated With a Decreased Risk of Clinical Rotavirus Vaccine Failure Among Children <2 Years of Age Participating in the Vaccine Impact on Diarrhea in Africa (VIDA) Study in Kenya, Mali, and the Gambia.
|
|
Academic Article
|
Mapping human norovirus antigens during infection reveals the breadth of the humoral immune response.
|
|
Academic Article
|
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants.
|
|
Academic Article
|
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.
|
|
Academic Article
|
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
|
|
Academic Article
|
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03 Adjuvant in Healthy US Adults.
|